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Objective:  To monitor  the presence  of pharmaceutical  residues  of  14 psychoactive  drugs  belonging  to
three therapeutic  groups  in  the watersheds  of Galicia  (Spain).
Method:  Five  sewage  treatment  plants  were  selected  in  the main  cities  of  Galicia.  Thirteen  psychoactive
pharmaceutical  compounds  and  one  metabolite  were  chosen.  In  addition,  tap water  samples  were  taken
from  public  places  and  private  residences  in  the  selected  cities.
Results:  In  all the  water  samples  analyzed,  the  highest  concentrations  corresponded  to  the  group  of
anxiolytics.  In  particular,  high  concentrations  of lorazepam  were  found  in river and tap  water  samples.
Conclusions:  This  investigation  demonstrates  the  presence  of psychoactive  pharmaceuticals  in the  water-
sheds of  the  autonomous  region  of Galicia  and the  conversion  of  metabolites  to  parent  compounds.  This
work also  shows  the need  to increase  environmental  monitoring  of  watersheds  and to improve  sewage
and drinking  water  treatment  processes  to remove  these  pharmaceuticals.
©  2011  SESPAS.  Published  by  Elsevier  España,  S.L.  All rights  reserved.
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Objetivo:  Monitorizar  la  presencia  de  14  fármacos  psicoactivos  pertenecientes  a tres  grupos  terapéuticos
en  la  cuenca  de  Galicia.
Método: Se  seleccionaron  cinco  estaciones  depuradoras  de  aguas  residuales  en  las  principales  ciudades
de Galicia.  Se  escogieron  trece  compuestos  farmacéuticos  psicoactivos  y  un metabolito.  Asimismo,  se
tomaron muestras  de  aguas  del grifo  de  espacios  públicos  y  privados  en  las  ciudades  seleccionadas.
Resultados:  En  todas  las  muestras  de agua  analizadas,  las mayores  concentraciones  han  correspondido
al  grupo  de  los  ansiolíticos,  y  especialmente  el lorazepam  ha  aparecido  en  altas  concentraciones  en las
muestras  de  aguas  de río  y  del  grifo.
Conclusiones:  Esta  investigación  demuestra  la  presencia  de  fármacos  psicoactivos  en  las  cuencas  de  Gali-
cia y la  reversión  de  los  metabolitos  a sus  compuestos  parentales.  Asimismo,  muestra  la necesidad  de
incrementar  la  monitorización  ambiental  de  las  cuencas  y de  mejorar  los  procesos  de  tratamiento  de las
aguas residuales  y potables  para  eliminar  estos  fármacos.
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Pharmaceuticals are used for many beneﬁcial purposes in mod-
rn society, but commonly constitute pollutants when encountered
n the environment1. Sometimes, these compounds are not man-
ged properly and are discharged directly into drains, while at other
imes they are not completely metabolized by the human body and
re excreted via urine and feces in sewage treatment plants (STPs).
harmaceuticals are not completely removed in STPs and may end
p in the environment.
Pollution by pharmaceuticals is recognized as an environ-
ental concern in many countries and has led to an extensiverea of research.2 Several therapeutic groups such as anti-
nﬂammatory and cardiovascular drugs, analgesics, antibiotics,
teroids and related hormones have been detected in the aquatic
∗ Corresponding author.
E-mail address: saraestgn@telefonica.net (S. Esteban).
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environment. In Spain, one of the most widely consumed drug
groups are psychoactive pharmaceuticals. The prevalence of the
total consumption of tranquilizers and relaxants was 17.4% (10.2%
men  and 17.5% women) in 2006.3 Several studies have shown
the occurrence of this group in the river and tap waters of the
Ebro Basin, Llobregat river, Region of Madrid and northwest of
Spain.4–8
The occurrence of pharmaceuticals in the environment leads
to various unanswered questions with regard to their biological
potency in ﬂora, fauna, and humans.2 Very few data are avail-
able on the presence of pharmaceuticals in point-of-use drinking
waters, partly due to the belief that modern treatment processes
will remove pharmaceuticals from potable supplies. Although the
risks associated with exposure to drugs are probably most signiﬁ-
cant with regard to the natural environment, the public’s concern
is understandably more focused on human exposure.9
The aim of this study was to monitor the presence of 14 psy-
choactive pharmaceutical residues belonging to three therapeutic
groups in Galicia’s watersheds.
ts reserved.
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Table 1
Characteristics of the sewage treatment plants selected in the watersheds of Galicia in 2008-2009.
STP code Basin Population equivalent Receiving water Treatment
Water Slugde
STP1 Galicia-Coast 9.407 Sar BAS + TT (NP + C) s
STP2  Galicia-Coast 358.257 Coast of A Corun˜a BAS + TT (UV) d + s
STP3  Galicia-Coast 111.240 Ría de Pontevedra PQ + BAS + TT (UV) bf
STP4 Galicia-Coast 8.234 Ría de Vigo BAS + TT (UV) s
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TP: sewage treatment plants; BAS: biologic-activated sludge; bf: belt ﬁlter-dryin
rying;  TT: tertiary treatment (UV: UV disinfection; NP: nitrogen and phosphorus r
ethod
The autonomous region of Galicia has a total area of 29,574.38
m2 and an estimated population of 2,796,089 inhabitants [5.98%
f the population of Spain, database of the National Institute of
tatistics (INEbase) 2009].
Five STPs were selected, one for each of the ﬁve main cities in
alicia: A Corun˜a, Ourense, Pontevedra, Santiago de Compostela
nd Vigo. For conﬁdentiality reasons, the citation order of the cities
oes not reﬂect the numeration of the STPs (table 1).
STP1 and STP5 discharge into surface waters of the basins of
alicia-Coast and Min˜o-Sil respectively, and the remainder (STP2,
TP3 and STP4) discharge directly into the sea. The sampling sta-
ions were carefully selected in order to produce consistent and
epresentative results for the ﬁnal interpretation of data. Pharma-
euticals were analyzed in the inﬂuent and efﬂuent water from
ll STPs and also 50 meters downstream of the emission points of
TP1 (DSSTP1) and STP5 (DSSTP5). Thirty-six grab samples were
ollected in three campaigns: August 2008, January 2009 and June
009. One sample for each campaign was taken from each sample
oint. Seventy-ﬁve tap water samples were also taken from public
laces and private residences of the cities selected in the same cam-
aigns as the wastewater and river water samples. Five samples for
ach campaign were taken in each city.
Thirteen pharmaceuticals and one metabolite were chosen
ecause of their potential toxicity and persistence in the envi-
onment. The pharmaceuticals analyzed are used as medications
or the central nervous system and belong to three of the most
requently prescribed therapeutic groups: antidepressants, anxi-
lytics and antiepileptics. The method described in the literature
nd used by Gros et al.5 was chosen for sample extraction and
nstrumental analysis.
able 2
ercentage (%) of samples and average concentrations (ng/L) with detectable concentra
ownstream rivers (DSSTP) and tap water in the watersheds of Galicia in 2008-2009.
N I (%) Average (ng/L) N E (%) Average (ng/L) 
Antidepressants
Amitriptiline 15 20 24 15 27 22 
Citalopram 15 33 114 15 73 149 
Clomipramine 15 - - 15 7 4 
Fluoxetine 15 7 16 15 60 28 
Nortriptiline 15 - - 15 13 11 
Sertraline 15 13 113 15 27 33 
Venlafaxine 15 47 401 15 67 317 
Antiepileptics
Carbamazepine 15 30 73 15 40 181 
Anxiolytics
-Alprazolam 15 13 20 15 - - 
Alprazolam 15 20 27 15 20 17 
Lorazepam 15 87 10598 15 67 689 
Nordiazepam 15 13 16 15 40 17 
Oxazepam 15 47 83 15 67 84 
Tetrazepam 15 40 92 15 53 64 
: percentage of samples with detectable concentrations in inﬂuent wastewater; E: perc
ercentage of samples with detectable concentrations 50 meters downstream of sewage Min˜o BAS + TT (NP) d + dt
naerobic digestion; PQ: physical-chemical processes; s: spin-drying; td: thermal
al; N: nitrogen removal; C: chlorination).
Results
Of  the 14 psychoactive pharmaceuticals analyzed, 12 were
detected in the wastewater samples of the STPs studied. However,
in some STP samples the concentrations were below the limit of
quantiﬁcation.
The percentage of samples and average values of detectable
concentrations in the inﬂuent and efﬂuent samples are shown
in table 2. Among 15 inﬂuent samples, venlafaxine was detected
in 43%, with an average concentration of 401 ng/L. Lorazepam
was found in 87% of inﬂuent samples with concentrations
of 10,598 ng/L. Among 15 efﬂuent samples, venlafaxine and
lorazepam were detected in 67%. The average concentrations
detected of venlafaxine and lorazepam were 317 ng/L and 689 ng/L,
respectively.
Most of the pharmaceuticals studied showed elevated concen-
trations in efﬂuents and in some samples the concentrations found
in the efﬂuents were higher than those detected in the inﬂuents.
The percentage of samples with detectable concentrations of
DSSTP1 and DSSTP5 reached 50% for venlafaxine and lorazepam
(table 2). The average concentration of lorazepam was  168 ng/L
while that of venlafaxine was  67 ng/L.
Among 75 tap water samples, lorazepam was found in 3%, with
an average concentration of 562 ng/L (table 2). Venlafaxine was
found in 1% of samples at concentrations of 44 ng/L.
DiscussionIn all the water samples analyzed, the highest concentrations
corresponded to the group of anxiolytics. In particular, lorazepam
was found in high concentrations in the river and tap water sam-
ples.
tions in the inﬂuent (I) and efﬂuent (E) wastewater of sewage treatment plants,
N DSSTP (%) Average (ng/L) N Tap water (%) Average (ng/L)
6 - - 75 - -
6 33 10 75 - -
6 - - 75 1 27
6 - - 75 - -
6 - - 75 - -
6 - - 75 - -
6 50 67 75 1 44
6 33 63 75 - -
6 - - 75 - -
6 17 17 75 1 11
6 50 167 75 3 562
6 - - 75 - -
6 - - 75 - -
6 - - 75 - -
entage of samples with detectable concentrations in efﬂuent wastewater; DSSTP:
treatment plants.
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What is known on this topic
Previous studies have focused on the detection of some
pharmaceutical groups in the environment. However there are
few studies on the presence of these compounds in tap water
and their possible effects on public health. Therefore, studies
are required not only to determine the presence of pharma-
ceutical residues in tap water, but also to identify their possible
effects on human health.
What does this study add to the literature?
This study demonstrates the presence of psychoactive phar-
maceuticals in natural and tap waters of the autonomous
region of Galicia and shows conversion of metabolites to par-
ent compounds. This work also highlights the need to increase
environmental monitoring of watersheds and to improve of
1
1
1
1
14.  Collier AC. Pharmaceutical contaminants in potable water: potential concernsS. Esteban et al. / Gac 
The average concentration of venlafaxine detected in efﬂuent
amples was similar to that reported in other works.7,11 However,
orazepam was found in higher concentrations than in other stud-
es. Coetsier et al.12 reported lorazepam levels of up to 200 ng/L
n treated sewage. In river waters, the concentration of lorazepam
as higher than that reported in the literature (40 ng/L). An impor-
ant aspect to highlight is the deconjugation phenomenon that
ay  occur in STPs. In some samples, the increase in pharmaceu-
icals in efﬂuents was demonstrated to occur due to conversion
f glucuronides and other conjugated metabolites to the parent
ompound by enzymatic processes taking place in the treatment
lant.10
The presence of lorazepam in drinking and tap waters has not
een studied in other works. The high concentrations detected in
ome tap water samples probably indicate that lorazepam is not
liminated by advanced drinking water treatments. In some cases,
nxiolytics are subject to illicit use by the population because of
heir properties13 and are also common in veterinary treatments.10
enzodiazepines are also used in stockbreeding, an important sec-
or of the Galician economy, and therefore this source should also
e considered.
Several studies have shown that the likelihood of acute effects
f such low pharmaceutical concentrations in drinking water is
ery low.7,9 However, little is known about the possible long-
erm effects of continuous exposure to low concentrations of these
harmaceuticals. Some authors suggest that although the conse-
uences in healthy adults would be negligible, in the young or
lderly these effects might be more pronounced due to reduced
bility to remove toxic compounds from their bodies. In addition,
n particular conditions such as allergies to certain compounds or
ulnerable life stages such as pregnancy the possible effects could
e more important.9,14,15 However, these afﬁrmations do not con-
titute proof because there are insufﬁcient studies in tap water
xposure.
The results obtained in this study are representative of the
atersheds of the autonomous region of Galicia but may  not be
xtrapolable to river and tap water from other areas. Another
imitation are the point measurements. A continuous monitoring
ystem would have been desirable to detect these compounds in
igher concentrations. Finally, the design of this investigation did
ot allow assessment of potential risks to public health.
To conclude, this study demonstrates the presence of psy-
hoactive pharmaceuticals in the watersheds of the autonomous
egion of Galicia and shows conversion of metabolites to parent
ompounds. This work also highlights the need to increase envi-
onmental monitoring of watersheds and to improve sewage and
rinking water treatment processes to remove these pharmaceuti-
als.
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